Page 34 - Read Online
P. 34

Page 12 of 15                                        Kumar et al. Mini-invasive Surg 2018;2:19  I  http://dx.doi.org/10.20517/2574-1225.2018.26

               Conflicts of interest
               The authors declare that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2018.


               REFERENCES
               1.   Bhangu A, Ali SM, Brown G, Nicholls RJ, Tekkis P. Indications and outcome of pelvic exenteration for locally advanced primary and
                   recurrent rectal cancer. Ann Surg 2014;259:315-22.
               2.   Georgiou PA, Tekkis PP, Brown G. Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options.
                   Cancer Imaging 2011;11:S103-11.
               3.   Georgiou PA, Tekkis PP, Constantinides VA, Patel U, Goldin RD, Darzi AW, John Nicholls R, Brown G. Diagnostic accuracy and value of
                   magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer 2013;49:72-81.
               4.   Georgiou P, Brown G, Constantinides V, Antoniou A, Nicholls R, Tekkis P. Diagnostic accuracy of MRI in assessing tumor invasion
                   within pelvic compartments in recurrent and locally advanced rectal cancer. Dis Colon Rectum 2009;52:9.
               5.   Denost Q, Kontovounisios C, Rasheed S, Chevalier R, Brasio R, Capdepont M, Rullier E, Tekkis PP. Individualizing surgical treatment
                   based on tumour response following neoadjuvant therapy in T4 primary rectal cancer. Eur J Surg Oncol 2017;43:92-9.
               6.   Smith JD, Nash GM, Weiser MR, Temple LK, Guillem JG, Paty PB. Multivisceral resections for rectal cancer. Br J Surg 2012;99:1137-43.
               7.   Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal
                   cancer beyond total mesorectal excision planes. Br J Surg 2013;100:1009-14.
               8.   Kim MJ, Chan Park S, Kim TH, Kim DY, Kim SY, Baek JY, Chang HJ, Park JW, Oh JH. Is lateral pelvic node dissection necessary after
                   preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node? Surgery 2016;160:366-76.
               9.   Kim MJ, Kim TH, Kim DY, Kim SY, Baek JY, Chang HJ, Park SC, Park JW, Oh JH. Can chemoradiation allow for omission of lateral
                   pelvic node dissection for locally advanced rectal cancer? J Surg Oncol 2015;111:459-64.
               10.  Yang TX, Morris DL, Chua TC. Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 2013;56:519-31.
               11.  Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, Heath RM, Brown JM; MRC CLASICC Trial Group. Short-term
                   endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre,
                   randomised controlled trial. Lancet 2005;365:1718-26.
               12.  Jeong SY, Park JW, Nam BH, Kim S, Kang SB, Lim SB, Choi HS, Kim DW, Chang HJ, Kim DY, Jung KH, Kim TY, Kang GH,
                   Chie EK, Kim SY, Sohn DK, Kim DH, Kim JS, Lee HS, Kim JH, Oh JH. Open versus laparoscopic surgery for mid-rectal or low-
                   rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised
                   controlled trial. Lancet Oncol 2014;15:767-74.
               13.  van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ; Colorectal Cancer Laparoscopic or Open Resection
                   II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised,
                   phase 3 trial. Lancet Oncol 2013;14:210-8.
               14.  Rodríguez-Sanjuán JC, Gómez-Ruiz M, Trugeda-Carrera S, Manuel-Palazuelos C, López-Useros A, Gómez-Fleitas M. Laparoscopic
                   and robot-assisted laparoscopic digestive surgery: present and future directions. World J Gastroenterol 2016;22:1975-2004.
               15.  Park S, Kim NK. The role of robotic surgery for rectal cancer: overcoming technical challenges in laparoscopic surgery by advanced
                   techniques. J Korean Med Sci 2015;30:837-46.
               16.  Lanfranco AR, Castellanos AE, Desai JP, Meyers WC. Robotic surgery: a current perspective. Ann Surg 2004;239:14-21.
               17.  Park EJ, Cho MS, Baek SJ, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Long-term oncologic outcomes of robotic low anterior
                   resection for rectal cancer: a comparative study with laparoscopic surgery. Ann Surg 2015;261:129-37.
               18.  Saklani AP, Lim DR, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Robotic versus laparoscopic surgery for mid-low rectal cancer after
                   neoadjuvant chemoradiation therapy: comparison of oncologic outcomes. Int J Colorectal Dis 2013;28:1689-98.
               19.  Xiong B, Ma L, Zhang C, Cheng Y. Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis. J Surg Res
                   2014;188:404-14.
               20.  Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M,
                   Bianchi PP, Edlin R, Hulme C, Brown J. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open
                   laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 2017;318:1569-80.
   29   30   31   32   33   34   35   36   37   38   39